Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57.
Posts Tagged ‘NASDAQ:CARA’
Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Latif and I will be your conference facilitator.
Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Cara Therapeutics' Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Lateef, and I will be your conference facilitator.
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. My name is Josh, and I will be your conference facilitator.
5 Medical Marijuana Stocks to Buy Now
In this article, we discuss 5 medical marijuana stocks to invest in.
10 Best CBD Stocks To Invest In
In this article, we discuss the 10 best CBD stocks to invest in.
Top 10 Stocks to Invest in Based on Traci Lerner’s Chescapmanager LLC’s Portfolio
In this article, we discuss the top 10 stocks to invest in based on Traci Lerner’s Chescapmanager LLC's portfolio.
5 Best CBD Stocks to Invest In
In this article, we will be looking at the 5 best CBD stocks to invest in.
Were Hedge Funds Right About Cara Therapeutics Inc (CARA)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
15 Most Valuable Weed Companies in the World
In this article we will take a look at the 15 most valuable weed companies in the world.
Is CARA A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Hedge Funds Are Crazy About Cara Therapeutics Inc (CARA)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Cara Therapeutics Inc (CARA) A Good Stock To Buy?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Was Smart Money Right About Piling Into Cara Therapeutics Inc (CARA) in September?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Here’s What Hedge Funds Think About Cara Therapeutics Inc (CARA)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
25 Biggest Marijuana Companies in the World
What are the biggest marijuana companies in the world? If you are looking for the safest investment, marijuana companies may just be the next big thing.
Did Hedge Funds Drop The Ball On Casa Therapeutics Inc (CARA) ?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is Casa Therapeutics Inc (CARA) Going to Burn These Hedge Funds?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Four Marijuana Stocks to Buy Now
The US marijuana industry has a lot of potential to grow and presents a good investment opportunity, although there is some uncertainty regarding the regulations.
Look Beyond Pharma to Invest in Marijuana Industry
In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ:CARA), Zynerba Pharmaceuticals...
Marijuana Stocks: Sean Williams, GW Pharmaceuticals PLC- ADR (GWPH), And Cara Therapeutics Inc (CARA)
One of the most compelling markets for investors is the burgeoning legal cannabis industry.
Donald Trump On Weed Legalization: What’s In Store For Marijuana Stocks?
While Canada is on the brink of legalizing Cannabis country-wide in 2017, the U.S is still engulfed in skepticism and legal ruffle about the substance.
12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
How Does Cara Therapeutics Inc (CARA) Stack Up Against Its Peers?
There are several ways to beat the market, and investing in small-cap stocks has historically been one of them.
How Hedge Funds Were Passing Around Marijuana Stocks in Q2
Even to people who are against the legalization of marijuana, it is common knowledge now that the legal marijuana industry is growing at a rapid pace and this growth should continue...
How Hedge Funds Traded Marijuana Stocks in Q1
The legalization of marijuana for recreational use in some regions has not only led to the formation of small companies that grow and sell marijuana, but has also given a boost...
Hedge Funds Think These 4 Marijuana Stocks Are Pretty Dope
A few years ago, most investors could not even fathom investing their money in companies dealing with illegal drugs.
Why Are Investors Bullish on These 4 Stocks Today?
European stock markets closed slightly lower on Wednesday and major US indices have also inched down so far in the intraday trading amid inflation data from China, which indicated...
Billionaire Steve Cohen Reveals Stake in Promising Biotech Company, While H Partners Cashes Out of Six Flags (SIX)
The 13F filings for the September quarter might be considered outdated by some market participants, as more than two months have already passed since the end of the quarter.
Ridgeback Capital’s Latest Healthcare Picks: Cara Therapeutics, Trillium Therapeutics and More
Incorporated in 2006, Ridgeback Capital was founded by Wayne Holman, with a major focus on the healthcare sector.
Deerfield Management Adds Cara Therapeutics Inc. (CARA) To Its Equity Portfolio
James E. Flynn’s Deerfield Management, in a filing with the Securities and Exchange Commission, reported a position in Cara Therapeutics Inc. (NASDAQ:CARA).
